Rapid responses are electronic comments to the editor. They enable our users
to debate issues raised in articles published on bmj.com. A rapid response
is first posted online. If you need the URL (web address) of an individual
response, simply click on the response headline and copy the URL from the
browser window. A proportion of responses will, after editing, be published
online and in the print journal as letters, which are indexed in PubMed.
Rapid responses are not indexed in PubMed and they are not journal articles.
The BMJ reserves the right to remove responses which are being
wilfully misrepresented as published articles or when it is brought to our
attention that a response spreads misinformation.
From March 2022, the word limit for rapid responses will be 600 words not
including references and author details. We will no longer post responses
that exceed this limit.
The word limit for letters selected from posted responses remains 300 words.
Answer to the title yes India can stop, but debatable point why are we disturbed with a never ending topic? A person with a little knowledge of Marketing management will agree with my proposition. This debate is having similarity with the topic like can we replace oxygen? The most scientific version of marketing will accept that marketing is also a science and pharmaceutical marketing is a step ahead, because we market science. According to my view we have to consider the issue with historical perspective consequently will stop blaming game, either doctor or even government while companies are not even exception. If we consider any single product of the world either having quality issue or regulatory issue or pricing issue and sometime values as issue. I believe present title should be addressed with the help of Value based marketing or holistic marketing because we have to consider who is payer? So every penny is having impact on the value creation process so only government regulation or blaming doctor is not a panacea rather a 360 degree approach in marketing practices could be a solution. While placing my view I would be candid with the point that giving gift to doctor is not issue but issue how are we giving and why are you giving while how much is also very important point. Thanks and regards.
Competing interests:
No competing interests
27 June 2013
Shantanu Chakravarty
Associate Professor
Parul Institute Of Management & Research
304-SAUNDARYA GREEN ONE, CANAL ROAD, TP-13 BARODA GUJARAT
Re: Can India stop drug companies giving gifts to doctors?
Answer to the title yes India can stop, but debatable point why are we disturbed with a never ending topic? A person with a little knowledge of Marketing management will agree with my proposition. This debate is having similarity with the topic like can we replace oxygen? The most scientific version of marketing will accept that marketing is also a science and pharmaceutical marketing is a step ahead, because we market science. According to my view we have to consider the issue with historical perspective consequently will stop blaming game, either doctor or even government while companies are not even exception. If we consider any single product of the world either having quality issue or regulatory issue or pricing issue and sometime values as issue. I believe present title should be addressed with the help of Value based marketing or holistic marketing because we have to consider who is payer? So every penny is having impact on the value creation process so only government regulation or blaming doctor is not a panacea rather a 360 degree approach in marketing practices could be a solution. While placing my view I would be candid with the point that giving gift to doctor is not issue but issue how are we giving and why are you giving while how much is also very important point. Thanks and regards.
Competing interests: No competing interests